 |
Cyclosporine in combination with omega-3 polyunsaturated fatty acids |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of solid organ graft rejection |
| USA Market Approval | USA |
| USA Designation Date | 2000-12-06 00:00:00 |
| Sponsor | RTP Pharma Corporation;200 Westpark Corporate Center, 4364 South Alston Avenue;Durham, North Carolina, 27713 |
